Black women with possible endometrial cancer were more likely than White women to experience testing delays or to not receive recommended tests at all, in a study of more than 44 million Medicaid patients across the United States. Early diagnosis of uterine cancer is known to improve a patient’s chances for survival. In the study, …
Black patients wait longer for endometrial cancer testing and diagnosis Read More »
In a study of nearly 15,000 cases of type II endometrial cancer between 2007 and 2016, the 5-year cancer-related death rate was 41% for Black women, compared with 32% for White and Hispanic women and 30% for Asian and Pacfic Islander women. The higher death rate was linked primarily to the women’s disease stage, tumor …
Black women more likely to die sooner than other women from type II endometrial cancer Read More »
Black women comprised only 7% and Hispanic women only 6% of the endometrial cancer clinical trials conducted between 1988 and 2019 that specified the race and ethnicity of participants. During that time period, less than 10% of the trials reported race and 5% reported ethnicity of the women. “The first step in addressing cancer care …
Black and Hispanic women missing from endometrial cancer clinical trials Read More »
Women who reported frequent use of hair straightening products, more than four times in a year, were more than twice as likely to go on to develop uterine cancer compared to those who did not use the products. That’s the finding of an study of nearly 34,000 U.S. women ages 35 to 74. Approximately 60% …
Hair straightening chemicals linked to higher risk of endometrial cancer Read More »
Endometrial cancer was long believed to be less common among Black women. But newer studies have confirmed that it is not only more likely to strike Black women but also more likely to be deadly. Black women die of uterine (endometrial) cancer at twice the rate of white women, according to a new report. The gap …
Endometrial cancer on the rise, especially among Black women Read More »
Uterine (endometrial) cancer deaths have been increasing in the United States, particularly among Black women. New research appears to pinpoint a cause. A rare but aggressive type of cancer known as Type 2 endometrial cancer is more difficult to treat and was responsible for 20% of cases and 45% of deaths identified in a new …
Endometrial cancer rates rising driven by aggressive cancers in Black women Read More »
Black patients undergoing treatment for gynecologic cancers report higher race-related stress as compared to White patients. The experience of racism was associated with increased treatment interruptions, increased length of treatment interruptions, and increased time to treatment initiation, in a survey of 70 Black and White women. “The experience of racism is associated with negative impacts …
Race-related stress linked to delays in treatment of gynecologic cancers Read More »
The incidence of high-risk uterine cancer is increasing in the United States, particularly among Black patients, according to a new study of nearly 800,000 women diagnosed with uterine cancer between 2001 and 2017. During that time, the incidence of uterine cancer increased regardless of race, but the rate was 3.6 times higher in Black patients …
Black and Hispanic patients were often underrepresented in individual clinical trials cited in the standard recommendations for systemic therapy for endometrial cancer, according to a survey of clinical studies. Black patients made up 7.4% of the clinical trials, but the percentage of Black patients with endometrial cancer was 10% of total patients in the U.S. …
Uterine (endometrial) cancer has pulled even with ovarian cancer as a leading cause of gynecologic cancer mortality, accompanied by an “alarming” racial disparity, reports Rebecca Siegel (above) of the American Cancer Society and her colleagues. Mortality patterns were similar among racial and ethnic groups until 2005, when uterine cancer mortality increased dramatically in Black women, …
Endometrial cancer deaths now even with deaths from ovarian cancer Read More »
Information provided on this website is neither intended nor implied to be a substitute for professional medical advice and is not intended to replace the services of a physician.
You should not use information on this web site or the information on links from this site to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider.
